Virtual Medicinal Product (VMP)
-
Retigabine 200mg tablets
Name Details
Current Name
Retigabine 200mg tablets
|
Start Date
05-05-2011
|
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.0
- UDFS UOM
- tablet
- Unit Dose UOM
- tablet
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral tablet
- Ontology Form/Route
- tablet.oral
- Non-availability Indicator
- Actual Products not Available
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
N03AX21
BNF |
Current BNF
04080100
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
04080100
|
Start Date
30-01-2012
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
42136211000001108 |
04-08-2023 |
|
704479005 |
02-04-2015 |
03-08-2023 |
18771711000001108 |
05-05-2011 |
01-04-2015 |
VMP Ingredients
VMP ingredients table
Retigabine |
Based on Ingredient Substance |
|
200 mg |
|
Name
Retigabine
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
200.0
Strength and UOM (Dmr)
Parent Products
-
VTM
Retigabine
-
VMP
(Current) Retigabine 200mg tablets
Virtual Medicinal Product Pack (VMPP) Information